Showing 761-770 of 951 results for "".
- Epilepsy: Charting a Course for Successhttps://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/pn0108-charting-a-course-pdf/31061/Optimizing Epilepsy Management: Strategic Approaches for NeurologistsEpilepsy treatment poses significant challenges for neurologists due to the complexity of accurate diagnosis and the plethora of available antiepileptic drugs (AEDs). In his January 2008 article in *Practical Neurology*, Dr. Steven
- Dementia Insightshttps://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/pn1207-dementiainsight-pdf/31076/Curcumin and Its Potential in Alzheimer's Disease ManagementAlzheimer’s disease (AD) remains a formidable challenge in neurology, prompting researchers to explore novel therapeutic avenues. One promising candidate is curcumin, a bioactive compound found in turmeric, a staple spice in South Asian cui
- Epilepsy Essentialshttps://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/PN1107epilepsy-pdf/31101/Febrile seizures are a prevalent neurological concern in pediatric populations, affecting approximately 4% of children in the United States. Typically occurring between one month and five years of age, with a peak incidence at 18 to 22 months, these seizures are triggered by febrile illnesses rather
- Pain Managementhttps://practicalneurology.com/diseases-diagnoses/headache-pain/pn0607-painmanagemnt-pdf/31166/Herbal Supplements Pose Significant Risks in Neurological CareHerbal supplements, often perceived as natural and safe, present considerable risks for patients undergoing neurological treatments. Dr. Charles Argoff, in Practical Neurology, highlights the critical need for healthcare professionals to
- Epilepsy Essentialshttps://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/pn0307-epilepsy-pdf/31201/Epilepsy and migraine are frequently comorbid neurological disorders, with individuals diagnosed with epilepsy experiencing a higher prevalence of migraine than the general population. Approximately 24% of epilepsy patients and 26% of their relatives report migraines, compared to a 15% prevalence in
- Dementia Insightshttps://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/PN0107DementiaInsight-pdf/31225/Linking Physical Activity to Cognitive Health in AgingRecent insights published in Practical Neurology highlight the significant relationship between physical activity and cognitive health in older adults, underscoring the potential to mitigate cognitive decline and reduce dementia risk through acti
- A Century of Alzheimer's: Progress and Pitfallshttps://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/pn1106-100years-pdf/31244/Alzheimer’s disease (AD), first identified by Alois Alzheimer in 1906 through the examination of Auguste D.’s brain, has evolved into one of the most extensively studied neurological disorders. Despite over a century of research, AD remains challenging to predict, diagnose accurately in living patie
- Business Advisorhttps://practicalneurology.com/columns/practice-management/business-advisor/31258/Medicare’s projected 5.1% reimbursement cuts for 2007 have reignited concerns among neurologists and other medical specialists about significant financial strain. If these cuts proceed as planned, physicians could see their earnings reduced by up to 40% by 2015. These reductions highlight underlying
- Growing Pains: Treating Migraine in Teens and Adolescentshttps://practicalneurology.com/diseases-diagnoses/headache-pain/PN0906GrowingPainsFEA-pdf/31271/Migraine during adolescence presents significant challenges, affecting over 10% of teenagers as they navigate physiological and social changes. The onset of migraine frequently begins in the teenage years, with females more likely to experience their first episode. Migraines with aura typically emer
- Pain Managementhttps://practicalneurology.com/diseases-diagnoses/headache-pain/PN0906painmanagement-pdf/31274/Topical Analgesic Therapy for Musculoskeletal Pain ManagementTopical analgesics present a valuable option for managing musculoskeletal pain, offering localized pain relief with minimal systemic absorption. In the first part of his two-part series, Dr. Charles Argoff explores the distinctions between